Gadobenate dimeglumine (Gd-BOPTA). An overview.

[1]  K. Hossmann,et al.  The effect of dexamethasone on serum protein extravasation and edema development in experimental brain tumors of cat , 2004, Acta Neuropathologica.

[2]  P. Taroni,et al.  Multihance clinical pharmacology: biodistribution and MR enhancement of the liver. , 1998, Academic radiology.

[3]  M. Moskowitz,et al.  Mismatch between cerebral blood volume and flow index during transient focal ischemia studied with MRI and GD-BOPTA. , 1998, Magnetic resonance imaging.

[4]  B. Jenkins,et al.  Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. , 1997, Investigative radiology.

[5]  V. Runge,et al.  Worldwide clinical safety assessment of gadoteridol injection: an update , 1997, European Radiology.

[6]  C. Kaeding,et al.  Meniscal flounce MR imaging. , 1997, Radiology.

[7]  C. Higgins,et al.  Alterations in T 1 of normal and reperfused infarcted myocardium after Gd‐BOPTA versus GD‐DTPA on inversion recovery EPI† , 1997, Magnetic resonance in medicine.

[8]  M. Taupitz,et al.  Liver metastases: improved detection with dynamic gadolinium-enhanced MR imaging? , 1997, Radiology.

[9]  F. Cavagna,et al.  Evaluation of the hepatocyte‐specific contrast agent gadobenate dimeglumine for MR imaging of acute hepatitis in a rat model , 1997, Journal of magnetic resonance imaging : JMRI.

[10]  M. Harisinghani,et al.  Contrast‐enhanced MR imaging of the liver: Comparison between Gd‐BOPTA and mangafodipir , 1997, Journal of magnetic resonance imaging : JMRI.

[11]  V. Lorusso,et al.  Hepatic transport of gadobenate dimeglumine in TR-rats. , 1996, Academic radiology.

[12]  B R Rosen,et al.  Non-Invasive Neurochemical Analysis of Focal Excitotoxic Lesions in Models of Neurodegenerative Illness Using Spectroscopic Imaging , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  E. Rummeny,et al.  Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. , 1996, Radiology.

[14]  W. Schima,et al.  Contrast-enhanced MR imaging. , 1996, Clinical radiology.

[15]  C. Higgins,et al.  Coronary artery stenosis: detection with contrast-enhanced MR imaging in dogs. , 1995, Radiology.

[16]  M. Taupitz,et al.  Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. , 1995, Radiology.

[17]  V. Lorusso,et al.  Hepatic transport of the magnetic resonance imaging contrast agent gadobenate dimeglumine in the rat. , 1995, Academic radiology.

[18]  D. Mitchell,et al.  Hepatic metastases and cavernous hemangiomas: distinction with standard- and triple-dose gadoteridol-enhanced MR imaging. , 1994, Radiology.

[19]  R. Edelman,et al.  Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. , 1994, Radiology.

[20]  M. Wendland,et al.  Binding of gadobenate dimeglumine to proteins extravasated into interstitial space enhances conspicuity of reperfused infarcts. , 1994, Investigative radiology.

[21]  A. Spinazzi,et al.  Interim results of phase II clinical testing of gadobenate dimeglumine. , 1994, Investigative radiology.

[22]  G. C. Hurst,et al.  Improved contrast of enhancing brain lesions on postgadolinium, T1-weighted spin-echo images with use of magnetization transfer. , 1994, Radiology.

[23]  M Lüning,et al.  Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging. , 1994, Radiology.

[24]  T. Murakami,et al.  3DFT‐FISP MRI with Gadopentetate Dimeglumine in Differential Diagnosis of Small Liver Tumors , 1994, Journal of computer assisted tomography.

[25]  K. Wolf,et al.  Peripheral washout: a sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions. , 1994, Radiology.

[26]  G. Schuhmann-Giampieri.  Liver contrast media for magnetic resonance imaging. Interrelations between pharmacokinetics and imaging. , 1993, Investigative radiology.

[27]  C. de Haën,et al.  Soluble‐type hepatobiliary contrast agents for MR imaging , 1993, Journal of magnetic resonance imaging : JMRI.

[28]  C. Compton,et al.  Enhancement of tumor‐liver contrast‐to‐noise ratio with gadobenate dimeglumine in MR imaging of rats , 1993, Journal of magnetic resonance imaging : JMRI.

[29]  R. Brasch.  New directions in the development of MR imaging contrast media. , 1992, Radiology.

[30]  C. McMahon,et al.  Gadobenate dimeglumine--a new contrast agent for MR imaging: preliminary evaluation in healthy volunteers. , 1992, AJR. American journal of roentgenology.

[31]  H. Weinmann,et al.  Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. , 1992, Radiology.

[32]  M. Bernardino,et al.  Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity. , 1992, Radiology.

[33]  S. Saini.  Contrast-enhanced MR imaging of the liver. , 1992, Radiology.

[34]  B. Drayer,et al.  Clinical safety and efficacy of gadoteridol: a study in 411 patients with suspected intracranial and spinal disease. , 1991, Radiology.

[35]  B. Hamm,et al.  Manganese‐DPDP as a Hepatobiliary Contrast Agent in the Magnetic Resonance Imaging of Liver Tumors: Results of Clinical Phase II Trials in Germany Including 141 Patients , 1991, Investigative radiology.

[36]  J. Mallada,et al.  MR and CT diagnosis of intracranial lipoma. , 1991, AJR. American journal of roentgenology.

[37]  V. Runge,et al.  Future directions in magnetic resonance contrast media , 1991, Topics in magnetic resonance imaging : TMRI.

[38]  C. D. Haën,et al.  Gadobenic Acid Dimeglumine Salt , 1991 .

[39]  R. Judd,et al.  Effects of barium-induced cardiac contraction on large- and small-vessel intramyocardial blood volume. , 1991, Circulation research.

[40]  K. Hossmann,et al.  Immunohistochemical study of glial reaction and serum-protein extravasation in relation to neuronal damage in rat hippocampus after ischemia , 1990, Neuroscience.

[41]  G. Vittadini,et al.  Preclinical profile of Gd-BOPTA. A liver-specific MRI contrast agent. , 1990, Investigative radiology.

[42]  J. Brown,et al.  Iron and Gadolinium Chelates as Contrast Agents in NMR Imaging: Preliminary Studies , 1984, Journal of computer assisted tomography.

[43]  G. Bydder,et al.  INTRAVENOUS CHELATED GADOLINIUM AS A CONTRAST AGENT IN NMR IMAGING OF CEREBRAL TUMOURS , 1984, The Lancet.

[44]  W. Hinshaw,et al.  Radiographic thin-section image of the human wrist by nuclear magnetic resonance , 1977, Nature.

[45]  P A Bottomley,et al.  NMR images by the multiple sensitive point method: application to larger biological systems. , 1977, Physics in medicine and biology.

[46]  P. Lauterbur,et al.  Image Formation by Induced Local Interactions: Examples Employing Nuclear Magnetic Resonance , 1973, Nature.

[47]  G. Arturson,et al.  Studies on Heart Lymph , 1964 .